(MENAFN- KNN India) REVE Antivirus launches Endpoint Security Solution for enterprises
New Delhi, May 21 (KNN) REVE Antivirus, an IT Security solution provider, has launched Endpoint Protection product, for Enterprise users which offers advanced security for enterprises using progressive and predictive machine learning algorithms.
'With the constant cyber threats erupting frequently such as Cerber ransom and Wanna Cry, it has become indispensable for organizations to strengthen their cyber defence mechanism and protect employees across multiple devices, the company said in a statement.
REVE Endpoint Security has high end features such as Device Control, Application Control, Asset Management to name a few.
CEO of REVE Antivirus, Sanjit Chatterjee said, 'We are very happy to launch REVE endpoint protection, which is the best product to combat advanced cyber threats on a bigger platform.
Along with comprehensive threat management, REVE Endpoint protection helps organization to secure their data safety by framing policies to block or allow permissions for using external devices such as Pen drive, Hard Disk, USB Dongle, External CD/DVD.
Data theft has been a constant challenge for organizations without a well-defined security policy. Applications like Skype, Facebook, Google Hangout etc. also pose a threat to organizations confidential data. REVE Endpoint security application control feature allows blocking of these application on all endpoints, the statement said.
With the new Endpoint security solution, managing organization's software & hardware assets becomes easy from a single console. IT admins can monitor software license & expiry of the entire network of systems from a single dashboard.
MENAFN2105201801550000ID1096888921
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.